|[June 11, 2014]
Research and Markets: Chronic Bronchitis - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/cv8lxd/chronic)
has announced the addition of the "Chronic
Bronchitis - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Chronic Bronchitis, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Chronic
Bronchitis and special features on late-stage and discontinued projects.
Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processs that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
The report provides a snapshot of the global therapeutic landscape of
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
The report reviews key players involved in the therapeutics
development for Chronic Bronchitis and enlists all their major and
The report summarizes all the dormant and discontinued pipeline
A review of the Chronic Bronchitis products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources
Nippon Shinyaku Co., Ltd.
Medestea Research & Production S.p.A.
Beech Tree Labs, Inc.
Theron Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/cv8lxd/chronic
[ Back To TMCnet.com's Homepage ]